Archives of Dermatological Research

, Volume 306, Issue 1, pp 51–58 | Cite as

MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population

  • Elizabeth Córdoba-Lanús
  • José G. Hernández-Jiménez
  • Chaxiraxi Medina-Coello
  • Adriana Espinoza-Jiménez
  • Ana González
  • María-del-Cristo Rodríguez-Pérez
  • Gregorio Carretero-Hernández
  • Pablo Almeida
  • José Suárez-Hernández
  • Antonio Perera-Molinero
  • Ricardo Fernández-de-MisaEmail author
Original Paper


Several MC1R variants are associated with increased risk of malignant melanoma (MM) in a variety of populations. We aim to examine the influence of the MC1R variants (RHC: D84E, R151C, R160W; NRHC: V60L, R163Q and the synonymous polymorphism T314T) on the MM risk in a population from the Canary Islands. Overall, 1,046 Caucasian individuals were included in the study. A thousand of them were genotyped for MC1R variants: 509 were sporadic MM patients and 491 were healthy control subjects from general population. The analysis was adjusted for age, sex, hair colour, eye colour, skin phototype and ancestry. We found that carriers of the R151C and R163Q variants were at an increased risk for melanoma OR 2.76 (1.59–4.78) and OR 5.62 (2.54–12.42), respectively. The risk of carrying RHC variants was 3.04 (1.90–4.86). Current study confirms the increased MM risk for R151C carriers. It also supports the association between R163Q variant and MM risk in the population on the Canary Islands, as opposed to reported on northern populations. These results highlight the importance of the sample population selection in this kind of studies.


Melanoma MC1R gene Variants Caucasians 



This research was supported by grants of the Fundación Canaria de Investigación y Salud (FUNCIS PI 47/05), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (FIS PI 08/0953, ISCIII) and Fundación Canaria del Instituto Canario de Investigación del Cáncer (FICIC, PI SE-10/13, ACIISI-FSE). The authors thank CEGEN for the Genotyping technology and Violeta Cazaña and Hilaria González for their excellent technical assistance.

Conflict of interest

The authors have no conflict of interest to declare.

Supplementary material

403_2013_1420_MOESM1_ESM.doc (59 kb)
Supplementary material 1 (DOC 59 kb)


  1. 1.
    Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG et al (2001) Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648PubMedGoogle Scholar
  2. 2.
    Barret JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefGoogle Scholar
  3. 3.
    Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA (2005) Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 14:2145–2154PubMedCrossRefGoogle Scholar
  4. 4.
    Beaumont KA, Shekar SL, Newton RA, James MR, Stow JL, Duffy DL, Sturm RA (2007) Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 16:2249–2260PubMedCrossRefGoogle Scholar
  5. 5.
    Beaumont KA, Liu YY, Sturm RA (2009) The melanocortin-1 receptor gene polymorphism and association with human skin cancer. Prog Mol Biol Transl Sci 88:85–153PubMedCrossRefGoogle Scholar
  6. 6.
    Cabrera de León A, González DA, Méndez LI, Aguirre-Jaime A, Rodríguez Pérez M, Coello SD, Trujillo IC (2004) Leptin and altitude in the cardiovascular diseases. Obes Res 12:1492–1498PubMedCrossRefGoogle Scholar
  7. 7.
    Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353(20):2135–2147PubMedCrossRefGoogle Scholar
  8. 8.
    Debniak T, Scott R, Masojc B, Serrano-Fernández P, Huzarski T, Byrski T et al (2006) MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 119(11):2597–2602PubMedCrossRefGoogle Scholar
  9. 9.
    de-Misa RF, Pérez-Méndez LI, Hernández-Jiménez JG, Mdel Rodríguez C, Vilar MC, Suárez J et al (2008) Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands. Int J Dermatol 47(8):806–811PubMedCrossRefGoogle Scholar
  10. 10.
    Duffy DL, Zhao ZZ, Sturm RA, Hayward NK, Martin NG, Montgomery GW (2010) Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J. Invest. Dermatol 130:520–528PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    F-de-Misa R, Hernández-Jimenez JG, Carretero Hernández G, Pérez-Méndez L, Aguirre-Jaime A, Flores C et al (2008) The D84E variant of the alpha-MSH receptor 1 gene is associated with cutaneous malignant melanoma early onset. J Dermatol Sci 52(3):186–192PubMedCrossRefGoogle Scholar
  12. 12.
    Fargnoli MC, Altobelli E, Keller G, Chimenti S, Hofler H, Peris K (2006) Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 16:175–182PubMedCrossRefGoogle Scholar
  13. 13.
    Fernandez LP, Milne RL, Bravo J, Avile′s JA, Longo MI Benítez J et al (2007) MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 28:1659–1664PubMedCrossRefGoogle Scholar
  14. 14.
    García-Borrón JC, Sánchez-Laorden BL, Jiménez-Cervantes C (2005) Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 18(6):393–410PubMedGoogle Scholar
  15. 15.
    Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT (2007) Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 28:495–505PubMedCrossRefGoogle Scholar
  16. 16.
    Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA (2005) Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 14:2208–2212PubMedGoogle Scholar
  17. 17.
    Harding RM, Healy E, Ray AJ, Ellis NS, Flanagan N, Todd C et al (2000) Evidence for variable selective pressures at MC1R. Am J Hum Genet 66:1351–1361PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A et al (2006) Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66:9330PubMedCrossRefGoogle Scholar
  19. 19.
    Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR (2010) Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 116(10):2416–2428PubMedCentralPubMedGoogle Scholar
  20. 20.
    Katsambas A, Nicolaidou E (1996) Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. Arch Dermatol 132(4):444–450PubMedCrossRefGoogle Scholar
  21. 21.
    Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117(2):294–300PubMedCrossRefGoogle Scholar
  22. 22.
    Kricker A, Armstrong BK, English DR, Heenan PJ (1995) A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 60:482–488PubMedCrossRefGoogle Scholar
  23. 23.
    Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T et al (2005) MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancet Inst 97:998–1007CrossRefGoogle Scholar
  24. 24.
    Maca-Mayer N, Villar J, Pérez-Méndez L, León A, Flores C (2004) A tale of aborigines, conquerors and slaves: Alu insertion polymorphisms and the peopling of Canary Islands. Ann Hum Genet 68:600–605CrossRefGoogle Scholar
  25. 25.
    Makova KD, Ramsay M, Jenkins T, Li WH (2001) Human DNA sequence variation in a 6.6-kb region containing the melanocortin 1 receptor promoter. Genetics 158(3):1253–1268PubMedGoogle Scholar
  26. 26.
    Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, Burnouf M et al (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41:e13PubMedCrossRefGoogle Scholar
  27. 27.
    Mössner R, Anders N, König IR, Krüger U, Schmidt D, Berking C et al (2007) Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 298(8):371–379PubMedCrossRefGoogle Scholar
  28. 28.
    Mountjoy G, Robbins S, Mortrud T, Cone D (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248–1251PubMedCrossRefGoogle Scholar
  29. 29.
    Nyholt DR (2004) A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 74:765–769PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC et al (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176–186PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Puig-Butillé JA, Carrera C, Kumar R, Garcia-Casado Z, Badenas C, Aguilera P, Malvehy J, Nagore E, Puig S (2013) Distribution of MC1R variants among melanoma subtypes: p. R163Q is associated with Lentigo Maligna Melanoma in a Mediterranean population. Br J Dermatol. doi: 10.1111/bjd.12418 PubMedGoogle Scholar
  32. 32.
    Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC (2008) MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122:2753–2760PubMedCrossRefGoogle Scholar
  33. 33.
    Rana BK, Hewett-Emmett D, Jin L, Chang BH, Sambuughin N, Lin M et al (1999) High polymorphism at the human melanocortin 1 receptor locus. Genetics 151:1547–1557PubMedGoogle Scholar
  34. 34.
    Raymond M, Rousset F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248–249Google Scholar
  35. 35.
    Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB (2004) Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 123:917–923PubMedCrossRefGoogle Scholar
  36. 36.
    Sánchez-Más J, Olivares-Sánchez C, Ghanem G, Haycock J, Lozano-Teruel A, Garcia-Borron C et al (2002) Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 269:6133–6141PubMedCrossRefGoogle Scholar
  37. 37.
    Savage SA, Gerstenblith MR, Goldstein AM, Mirabello L, Fargnoli MC, Peris K, Landi MT (2008) Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene MC1R. BMC Genet 9:31PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Scherer D, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Hemminki K, Kumar R (2008) MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer 122:1787–1793PubMedCrossRefGoogle Scholar
  39. 39.
    Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK et al (2009) Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 125(8):1868–1875PubMedCrossRefGoogle Scholar
  40. 40.
    Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929PubMedCrossRefGoogle Scholar
  41. 41.
    Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 73:1162–1169PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Stratigos AJ, Dimisianos G, Nikolaou V, Poulou M, Sypsa V, Stefanaki I et al (2006) Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 126:1842–1849PubMedCrossRefGoogle Scholar
  43. 43.
    Van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA (2001) Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69(4):774–779PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Williams PF, Olsen CM, Hayward NK, Whiteman DC (2011) Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 129(7):1730–1740PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Elizabeth Córdoba-Lanús
    • 1
  • José G. Hernández-Jiménez
    • 2
  • Chaxiraxi Medina-Coello
    • 1
  • Adriana Espinoza-Jiménez
    • 1
  • Ana González
    • 1
  • María-del-Cristo Rodríguez-Pérez
    • 1
  • Gregorio Carretero-Hernández
    • 3
  • Pablo Almeida
    • 4
  • José Suárez-Hernández
    • 5
  • Antonio Perera-Molinero
    • 6
  • Ricardo Fernández-de-Misa
    • 1
    • 5
    Email author
  1. 1.Research UnitHospital Universitario Nuestra Señora de CandelariaSanta Cruz de TenerifeSpain
  2. 2.Pharmacology Unit, Antonio González Bio-Organic Universitary InstituteUniversity of La LagunaSanta Cruz de TenerifeSpain
  3. 3.Dermatology DepartmentHospital Universitario Dr. NegrínLas Palmas de Gran CanariaSpain
  4. 4.Dermatology DepartmentHospital Universitario InsularLas Palmas de Gran CanariaSpain
  5. 5.Dermatology DepartmentHospital Universitario Nuestra Señora de CandelariaSanta Cruz de TenerifeSpain
  6. 6.Pathology DepartmentHospital Universitario Nuestra Señora de CandelariaSanta Cruz de TenerifeSpain

Personalised recommendations